Use the table below to answer the following question(s). Dresden Pharmaceuticals has decided to go ahead and start clinical trials on a potential new drug. The total R&D costs are estimated to reach around $875,000,000 with clinical trials mounting to $145,000,000. The current market size is estimated to be around 3,000,000 and is expected to grow at 4 percent every year. The market share Dresden hopes to capture in the first year is 7 percent, and is projected to grow by 25 percent each year for the next 4 years. A monthly prescription is anticipated to generate revenue of $420 while incurring variable costs of $150. A discount rate of 8 percent is assumed.

Dresden Pharmaceuticals
Data
Market Size	3,000,000
Unit (monthly Rx) revenue ($)	420
Unit (monthly Rx) cost ($)	150
Discount Rate ( per cent)	8
Project Costs
R&D ($)	875,000,000
Clinical Trials ($)	145,000,000

Calculate the annual revenue for the fourth year.